HOME >> BIOLOGY >> NEWS
Possible Dangers Of Taking Over-The-Counter Medications For Hepatitis C Patients

HERSHEY, PA-- Patients with chronic hepatitis C often take the over-the-counter non-steroidal drug Ibuprofen, otherwise known as Motrin or Advil, to combat joint pain that often accompanies the disease. Even a low dose could lead to unsuspecting liver damage.

"Patients frequently suffer from joint pain. Often, even physicians will prescribe ibuprofen when they should prescribe Tylenol," explains Thomas Riley, III, M.D., assistant professor of medicine at Penn State's College of Medicine. "The correct recommendation to help the patient is a low dose of Tylenol, about 2 grams per day. That means the patient can take one extra strength Tylenol -- 500 mg -- every six hours or take two every 12 hours."

Riley and his colleagues describe three cases in an article, "Ibuprofen Induced Hepatoxicity in Those With Chronic Hepatitis C: A Case Series," published in the September issue of the American Journal of Gastroenterology.

In each of these three cases the patients have hepatitis C and took over-the-counter ibuprofen. After doing so they all had a flare-up of their hepatitis.

"Many physicians don't want to prescribe Tylenol because it has a reputation of causing liver damage. As long as it is prescribed in the low doses we have discussed it is definitely the best treatment," explains Riley, who is also the medical director for the liver transplant program at The Milton S. Hershey Medical Center of the Penn State Geisinger Health System. He also says where patients with chronic hepatitis C usually have mild elevations in their liver enzymes in the blood, after taking the over-the-counter Ibuprofen these patients experience a ten-fold rise in their enzymes, suggesting significant liver injury.

He adds that if too much medication is taken the patient risks speeding up the process of going from chronic hepatitis to cirrhosis of the liver.

Riley says that about four million Americans are infected with he
'"/>

Contact: Leilyn Perri
lperri@psghs.edu
(717) 531-8604
Penn State
16-Sep-1998


Page: 1 2

Related biology news :

1. Possible new cure for psoriasis
2. Possible link discovered between gene responsible for blood vessel development and ACD in newborns
3. Possible mechanism for link between diabetes and Alzheimers disease discovered
4. Scientists switch components in cell circuits: Possible new technology, therapy
5. Possible new cell type found in developing inner ear
6. Possible gene for form of mental retardation, brain development identified
7. Possible cause and treatment for shock uncovered by UC San Diego bioengineers
8. Reproductive Signals Affect Lifespan In Roundworm C. Elegans, Offering Possible Insight Into Human Aging Process
9. UV Rays, Fire And Flame Retardants To Be Reviewed For Possible Listing As Carcinogens, NTP Announces
10. Coffee Without Addiction, Possible New Treatment For Osteoporosis, Wrinkle-Free Cotton, And More
11. Mechanism For Fungal Adherence Found, Possible Key To Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... Amplify Surgical, ... with the dualX Expanding Interbody Fusion System. , The landmark case was ... After the case Dr. Najafi noted, “dualX has completely changed the game for ...
(Date:3/2/2020)... , ... March 02, 2020 , ... Philadelphia IP law ... Bliss, Ph.D., J.D. has joined the firm as a Partner, and Stephany G. Small, ... an experienced patent attorney and will be a partner in the firm’s biotechnology and ...
(Date:2/28/2020)... ... , ... Meridian Clinical Research , a leading investigative research network, is ... Best Clinical Trial Site. Meridian is also the largest member of Platinum Research ... nominations were the result of two voting rounds, and winners will be announced at ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a global leader ... announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen in a gel testing ... run on ORTHO VISION® and ORTHO VISION® Max in the United States and Canada. ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... recombinant antibody products and services, today announced the launch of its FleXpress™ ... express a large number of antibodies at 80 ml scale. All production ...
(Date:3/3/2020)... , ... March 03, 2020 , ... ... invited to present the latest breast implant technology at the IMCAS Innovation Shark ... new innovations in the dermatology, plastic surgery, and aesthetic science industries that promise ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing its leading ... the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) HMO. ... milk. These complex carbohydrates are indigestible and therefore function as a prebiotic by ...
Breaking Biology Technology:
Cached News: